Trump
Trump’s Blueprint on International Drug Pricing; What to Expect
The U.S. always stood out as a different healthcare system. Well, maybe not anymore. The Trump Administration released an International Drug Pricing blueprint in 2018 and it was received with…
Discount Safe Harbor Proposed Rule: How Process Works and What does it mean?
July 2019 Update As first reported by The Wall Street Journal and Axios on July 11, 2019, the Trump Administration has decided to abandon implementation of the proposed Discount Safe…
Proposed Per Capita Cap on Medicaid Payments – Manufacturer Implications
Special thanks to co-writer Neelabh Saxena, Associate Director Pricing, Contracting, and Market Access.
The Fate of the Affordable Care Act
The dawn of a new healthcare landscape is upon us. But what exactly it may look like when the dust of the new Trump Administration settles is anyone’s guess.
Beyond ACA: Evaluating Impacts on the Retailization of Healthcare
While components of the Affordable Care Act (ACA) are expected to come under significant scrutiny from the Trump Administration and Congress, the ongoing “retailization” of healthcare will accelerate regardless of…
Post-Election Predictions for the Healthcare Industry
It’s been nearly a month since Donald Trump won the election to become the next President of the United States. In those four weeks, industry experts and healthcare executives have…